ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients with Severe Sepsis

Update Il y a 4 ans
Reference: EUCTR2005-005537-35

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To demonstrate that eritoran tetrasodium treatment of subjects with severe sepsis results in a reduction in 28-day all-cause mortality.


Inclusion criteria

  • Severe sepsis